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Solution Structure of Human
Initiation Factor eIF2 Reveals Homology
to the Elongation Factor eEF1B
nus and a zinc binding motif near the C terminus. The
lysine blocks play a role in binding to the heteropentam-
eric guanine nucleotide exchange factor (GEF) eIF2B
and the GAP eIF5 (Asano et al., 1999), and the zinc
binding motif seems to be involved with a regulation of
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et al., 1997).
The  subunit is considered to function primarily as
a regulatory element of eIF2 and is the target of manySummary
eIF2 kinases that are activated by various forms of cell
stress: the double-stranded RNA-activated kinase PKRThe GTP-bound form of the trimeric eukaryotic trans-
is activated by virus infection (Kaufman, 2000), the heme-lation initiation factor 2 (eIF2) transfers aminoacylated
regulated inhibitor HRI by iron deficiency (Chen, 2000),initiator methionyl tRNA onto the 40S ribosome. We
the PKR-like endoplasmic reticulum kinase PERK byhave solved with solution NMR the structure of the 
increased amounts of unfolded proteins in the endoplas-subunit of human eIF2 (heIF2). The protein consists
mic reticulum (Ron and Harding, 2000), and the Saccha-of two domains that are mobile relative to each other.
romyces cerevisiae protein kinase GCN2 and its mam-The N-terminal domain has an S1-type oligonucleo-
malian homolog by amino acid starvation (Hinnebusch,tide/oligosaccharide binding-fold subdomain and an
1996). Ser51 in eIF2 has been identified as a phosphor--helical subdomain. The C-terminal domain adopts
ylation site for these kinases. Previous studies havean -fold very similar to the C-terminal domain of
shown that phosphorylation of Ser51 in eIF2 results inelongation factor (eEF) 1B, the guanine-nucleotide
a strong inhibition of translation initiation. This is causedexchange factor for eEF1A. The structural and func-
by an increased affinity of phosphorylated eIF2 fortional similarities found between eIF2/eIF2 and
eIF2B, which results in a decreased GDP/GTP exchangeeEF1B/eEF1A suggest a model for the interaction of
rate on eIF2, and thus a decreased population of theeIF2 with eIF2, and eIF2 with Met-tRNAiMet. It further
activated GTP-bound form of eIF2 (Pavitt et al., 1998).indicates a previously unrecognized evolutionary lin-
Here, we present the solution structure of humaneage of eIF2/ from the functionally related elonga-
eIF2 determined with NMR spectroscopy. The struc-tion factor eEF1B/eEF1A complex.
ture shows that eIF2 consists of two domains that are
mobile relative to each other. The N-terminal domain
Introduction (NTD) contains two subdomains and is consistent with
the previously determined crystal structure (Dhaliwal
Translation initiation is a crucial stage for the control of and Hoffman, 2003; Nonato et al., 2002), and the C-ter-
protein expression in cell development, differentiation, minal domain (CTD), for which no previous structural
and apoptosis. In eukaryotes, translation initiation is information had been available, has an -fold. Surpris-
regulated mainly by the various specific interactions ingly, this domain exhibits a fold and shape closely simi-
among eukaryotic initiation factors (eIFs), mRNA, and lar to the CTD of the translation elongation factor
the ribosome (Hershey and Merrick, 2000). Aminoacy- eEF1B, despite the lack of any sequence homology.
lated initiator methionyl tRNA (Met-tRNAiMet) is recruited eEF1B functions as a GEF for eEF1A. The latter is
to the 40S ribosomal subunit by eIF2, which consists of known to be homologous to eIF2 (Schmitt et al., 2002).
, , and  subunits. Previous studies have shown that Thus, our finding reveals a new case of molecular simi-
binding of Met-tRNAiMet to eIF2 primarily involves the  larity between elongation and initiation machinery and
subunit (Erickson and Hannig, 1996). eIF2 is a guanine indicates a common evolutionary origin for eIF2 and
nucleotide binding protein (G protein) sharing sequence eEF1B. Based on these structural similarities, a possi-
and structural similarities with both the prokaryotic elon- ble model for the function of the CTD of eIF2 is pre-
gation factor EF1A (formerly called EF-Tu) and the eukary- sented.
otic elongation factor eEF1A (Schmitt et al., 2002). Like
the GTP-bound EF1A and eEF1A, which bind aminoacy-
lated tRNA (aa-tRNA), the GTP-bound eIF2 forms a stable Results and Discussion
ternary complex with Met-tRNAiMet (Gaspar et al., 1994).
After the establishment of the interaction between the Structure Determination of heIF2 by NMR
anticodon in Met-tRNAiMet and the AUG start codon on In order to solve the structure of heIF2, we planned to
the 40S ribosome, hydrolysis of eIF2-bound GTP is stim- produce isotope-labeled protein in E. coli expression
ulated by the GTPase-activating protein (GAP) eIF5, and systems. However, very low expression levels were en-
the eIF2-GDP complex is released from the ribosome, countered for wild-type heIF2, and the expressed pro-
followed by joining of the 60S ribosomal subunit. The  tein was soluble only up to 0.05 mM concentrations. This
subunit of eIF2 contains lysine blocks near the N termi- was sufficient for recording a 1H-15N HSQC spectrum but
did not allow for assignments and structure determina-
tion. To overcome this problem, we pursued the follow-*Correspondence: wagner@hms.harvard.edu
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Figure 1. Primary Sequence Alignment of eIF2 and the eEF1B-CTD
Sequences of eIF2 from Homo sapiens (HUMAN), Rattus norvegicus (RAT), Drosophila melanogaster (DROM), Schizosaccharomyces pombe
(SCHP), Saccharomyces cerevisiae (YEAST), Sulfolobus tokodaii (SULTO), Methanococcus jannaschii (METJ), Sulfolobus solfataricus (SULSO),
and Pyrobaculum aerophilum (PYRAE), and those of the eEF1B-CTD from H. sapiens (HUMAN) and S. cerevisiae (YEAST) were aligned using
ClustalX (Thompson et al., 1997) with additional manual correction, and a figure was created using Alscript (Barton, 1993). Highly and completely
conserved residues of eIF2 were colored with yellow and red, respectively, and conserved ones in both human and yeast eEF1Bs are
colored with yellow. Identified secondary structural elements of eIF2 are shown above with blue and red for the NTD and the CTD, respectively,
and those of the yeast eEF1B-CTD (Andersen et al., 2000) are shown below with light magenta. Residue numbers for the human eIF2 and
the yeast eEF1B are shown every ten residues by black small-sized letters. The mutated positions, N terminus, and C terminus for se-heIF2
are shown by black middle-sized letters. In the eIF2 sequences, the phosphorylation site Ser51, the mutation positions Pro13/Val19 found
in sui2 suppressors, the positions of Arg243/Lys275, and the positions of Thr244/Met272 are indicated by a red asterisk, red open squares,
green open circles, and green open stars, respectively. The positions of Phe163 and Lys205 of yeast eEF1B are indicated by a red filled
square and a green filled circle, respectively.
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ing steps: First, we produced an artificial gene optimized tained distance restraints from 2D NOESY, 3D 13C-edited
NOESY-HSQC, and 3D 15N-edited NOESY-HSQC spec-for E. coli codon usage in order to boost the expression
level. Second, we introduced a helper plasmid for chap- tra of C-heIF2. The final ensembles of structures for
NTD and CTD are shown in Figures 2A and 2B, respec-erone coexpression, which dramatically increased the
fraction of correctly folded and soluble protein. Third, tively, and a ribbon model of heIF2 is depicted in Figure
2C. Statistics for the final structures are shown in Tableto increase the solubility of the expressed protein, we
introduced hydrophobic-to-hydrophilic mutations for 1. Backbone rmsds of the refined regions in NTD (resi-
dues 6–47 and 62–184) and CTD (residues 187–277) arenonconserved residues we guessed to be on the protein
surface and functionally unimportant. This procedure 1.23 A˚ and 0.58 A˚, respectively.
allowed us to produce from a 1 liter expression volume
a 0.5 mM sample that is well behaved and stable (Ito heIF2 Consists of Two Globular Domains
and Wagner, 2004). The resulting expression-improved that Are Mobile Relative to Each Other
and solubility-enhanced mutant, named se-heIF2, com- Primary sequences of eIF2 from several representative
prises residues Ser4 to Asp302 and contains three muta- species are aligned in Figure 1. Amino acid residues
tions, A27Q, L46H, and V71K, as shown in Figure 1. The between Arg6 and Glu273 are highly conserved among
1H-15N HSQC spectra of a wild-type heIF2 and a se- all species including archaea (no homolog is known for
heIF2 were similar, which indicated that the solubility- eubacteria). The lowest sequence conservation is found
enhancing mutations did not change the tertiary struc- for some loops and terminal regions of  helices. This
ture (Ito and Wagner, 2004). Thus, we decided to use fact strongly suggests that the tertiary structure of eIF2
se-heIF2 to determine the tertiary structure. We use is conserved among all species. As mentioned above,
the word heIF2, instead of se-heIF2, generally during the calculated heIF2 NMR structure revealed that it
discussion of the structure, except when a distinction consists of two domains, NTD and CTD, and a C-terminal
is necessary. tail found only in eukaryotes. Figure 3A is an overlay
Since the molecular weight of se-heIF2 is more than of the 1H-15N HSQC spectra of N-se-heIF2 (blue) and
35 kDa and relatively large for the NMR study, a 2H/13C/ C-heIF2 (red), and Figure 3B shows 1H-15N HSQC spec-
15N-labeled sample was required to record high-quality trum of se-heIF2. Except for the line widths and the
TROSY-based NMR spectra for backbone assignment positions of some peaks at the domain boundary, the
(Salzmann et al., 1998). In order to obtain distance restraints vast majority of peaks in Figure 3A are identical to those
from nuclear Overhauser effect (NOE), a U-2H-/U-12C-/ in Figure 3B. We also performed a mixing experiment,
U-15N-/ILV-methyl-1H,13C-/FY-1H-labeled sample (ILVFY- recording 1H-15N HSQC spectra of 15N-labeled N-se-heIF2/
sample) was prepared, which has a 2H/12C/15N-labeled C-heIF2 in the presence or absence of unlabeled
background but contains 1H,13C-labeled methyl groups C-heIF2/N-se-heIF2. The recorded HSQC spectra
at the positions 1 in isoleucine, 1 and 2 in leucine, showed no difference between the presence and the
and 1 and 2 in valine, and protonated phenylalanines absence of the other domain (data not shown). These
and tyrosines (Gross et al., 2003; Hajduk et al., 2000). results indicate that the NTD and CTD are folded by
The “ILVFY-sample” made it possible to record various themselves, adopt the same conformation as in full-
NOESY spectra at high sensitivity for measuring NOE length heIF2, have little interdomain contact, and are
cross peaks between protons in amide, ILV-methyl, and mobile with respect to each other. These findings are
FY-aromatic groups. The large number of NOEs identi- consistent with the fact that only the NTD was crystal-
fied this way, together with other conventional NMR- lized after proteolysis from the full-length heIF2 (Dhali-
derived and statistics-based restraints, were sufficient wal and Hoffman, 2003; Nonato et al., 2002). It is likely
to calculate a tertiary structure of heIF2. that the relative orientation of the two domains will be
While proceeding with the structure determination, it fixed or restricted in the context of trimeric eIF2 and/
became obvious that heIF2 consists of two indepen- or in the ternary complex of eIF2 with GTP and Met-
dently moving globular domains. This became evident tRNAiMet.because no long-range NOEs were observed between
the N-terminal domain (NTD, residues 4–184) and the
The N-Terminal Domain ConsistsC-terminal domain (CTD, residues 185–302). Thus, we
of Two Subdomains: S1 Subdomaindesigned expression systems for the two putative do-
and -Helical Subdomainmains, N-se-heIF2 and C-heIF2. Both domains ex-
The NTD consists of two subdomains, S1 subdomainpressed well and exhibited good 1H-15N HSQC spectra.
(residues 15–85) and -helical subdomain (residues 91–The spectra of the isolated domains were nearly identi-
183), and the NMR structure of the NTD agreed almostcal to those in the full-length construct, which indicated
completely with the recently determined crystal struc-that both domains are folded alone and adopt the same
ture of the NTD of heIF2 (Nonato et al., 2002). The S1conformation as in the context of the entire heIF2 (see
subdomain consists of a five-stranded -barrel andbelow). Since the NOE-derived distance restraints be-
adopts the so-called OB fold that was originally identi-tween amide,  and  protons in NTD were obtained
fied in the ribosomal protein S1 (Arcus, 2002). Strandseasily using 2D NOESY, 3D 15N-edited TOCSY-HSQC,
3 and 4 are connected by a long loop (the 3/4 loop)and 3D 15N-edited NOESY-HSQC spectra of N-se-heIF2,
that contains two 310 helices, 310A (residues 47–50) andwe adopted these restraints for the calculations of the
310B (residues 58–61) (Figures 2A and 2C). In many otherstructure of full-length heIF2. To obtain a more precise
OB folds, this loop contains a single helix. The phosphor-structure, we assigned most of the side chain reso-
nances in the CTD by conventional methods and ob- ylation site, Ser51, is located just after helix 310A in the
Structure
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Figure 2. NMR Structure of heIF2
(A and B) The backbone wire presentations of the NTD (A) and the CTD (B) in heIF2 with parallel stereoviews. Fifteen structures are fit onto
the mean positions.
(C) The ribbon presentation of heIF2 is shown with the secondary structural elements. While the  helices and the  sheets in the NTD are
colored with blue and cyan, respectively, those in the CTD are colored with red and orange, respectively. All structure figures were created
with MolMol (Koradi et al., 1996).
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two 310 helices at the N and C-terminal ends, which areTable 1. Statistics of 15 NMR Final Structures
very similar to those in the NMR structure of heIF2.
NOE distance restraints (no.) Total (residues 4–185/186–302)
The primary sequences in the 3/4 loop are highlyAmbiguous 114 (78/36)
conserved among eukaryotes as shown in Figure 1.Unambiguous
Thus, the3/4 loop structure may be conserved amongIntraresidue 276 (173/103)
Sequential (|i  j|  1) 519 (300/219) eukaryotes. In addition, the recognition mechanism of
Middle range (2  |i  j|  4) 351 (232/119) both phosphorylated and unphosphorylated Ser51 by
Long range (|i  j|  4) 575 (315/260) eIF2-kinases or eIF2B might also be conserved. The
Total 1835 (1098/737)
side chains of the three mutated residues, Glu27, His46,Hydrogen bond distance 236 (152/84)
and Lys71, are solvent exposed and do not form struc-restraints (no.)
turally important contacts with other side chains as weBackbone dihedral angle 394
restraints (φ and 	) (no.) had expected.
13C chemical shift restraints (no.) The -helical subdomain consists of five  helices
C 271 (helices 1, 2, 3, 4, and 5) and one 310 helix (helix 310C)
C 188
packing together compactly. There is an aromatic hy-Rmsds from idealized covalent
drophobic core between the S1 and -helical subdo-geometry
mains, consisting of Phe7, Tyr8, Tyr38, Phe101, Tyr108,Bonds (A˚) 0.0025 
 0.0001
Angles () 0.554 
 0.007 Phe130, and Trp135 (Figure 4). This group of residues
Impropers () 0.412 
 0.008 appears to be one of the forces stabilizing the interaction
Ramachandran plot (%) between the S1 and -helical subdomains in the NTD.
Most favored regions 74.5
In the crystal structure of the human NTD, Cys69 fromAdditionally allowed regions 21.3
strand 4 in the S1 subdomain and Cys97 from helix 1Generously allowed regions 3.3
in the -helical subdomain are linked by a disulfide bondDisallowed regions 1.0
Average rmsds from mean structure (Nonato et al., 2002). Since the NMR buffer contains 10
(backbone atoms/heavy atoms) (A˚) mM dithiothreitol, this bond was not detected in the
NTD (residues 6–47 and 62–184) 1.23/1.88 NMR sample protein, which was indicated by the C
CTD (residues 188–277) 0.58/1.19 chemical shift value of Cys69 (not detected for Cys97).
Data were analyzed by NIH-XPLOR (Brunger, 1992), MOLMOL (Kor- Because the redox potential of the cytoplasm provides
adi et al., 1996), and PROCHECK NMR (Laskowski et al., 1996). reducing conditions and the cysteine residues above
are not highly conserved among eIF2s, the disulfide
bond in the crystal structure may have been formed
3/4 loop. In the crystal structure, the electron density during the crystallization under nonphysiological oxidiz-
of the residues between Ser51 and Ile62 was missing ing condition. The distance between the S atoms of
(Nonato et al., 2002). This could be because the heIF2 the two cysteines is 6.64 
 1.84 A˚, which is inconsistent
3/4 loop is more mobile than the rest of the NTD. The with the existence of a disulfide bond.
crystal structure of the NTD from S. cerevisiae eIF2was In the yeast system, the gene encoding eIF2 is known
also determined very recently (Dhaliwal and Hoffman, as SUI2 (suppressor of initiator codon mutations 2 ).
2003), and in that structure the backbone electron den- Previous studies have shown that subunit-deleted eIF2
sity in the3/4 loop was visible. Interestingly, the3/4 has defects in eIF2B-catalyzed nucleotide exchange and
Met-tRNAiMet binding (Nika et al., 2001) and is lethal inloop in the S. cerevisiae crystal structure also possesses
Figure 3. The NTD or the CTD Alone Folds the Same as the Full-Length heIF2
(A) The 1H-15N HSQC spectra of N-se-heIF2 and C-heIF2  are shown with blue and red, respectively, overlaid in the same frame.
(B) The 1H-15N HSQC spectrum of se-heIF2 is shown.
Structure
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Figure 4. Key Residues in the NTD of eIF2
The residues in the hydrophobic aromatic
cluster between S1 subdomain and -helical
subdomain, and the mutated residues in the
sui2 suppressors are shown. The side chains
from Phe7, Tyr8, Tyr38, Phe101, Tyr108,
Phe130, and Trp135 are shown on the ribbon
model. Phenylalanine, tyrosine, and trypto-
phan are colored with green, magenta, and
yellow, respectively. The side chains of Pro13
and Val19, which are the mutated residues
found in the sui2 suppressors, are shown
with red.
yeast. However, this lethality is suppressed by overex- ranged in the order 7, 8, 6, and 9/10. Strands 9
and 10 both pair with 6 but are interrupted by a bulgepression of the  and  subunits of eIF2 and tRNAiMet
(Erickson et al., 2001). Recently, Yatime and colleagues containing residues Glu271–Pro274. Helices 6 (204–
216) and 7 (243–262) connect strands 6 with 7, andshowed that in the archaeal system the S1 subdomain
in the NTD binds RNA nonspecifically, and the CTD 8 with 9, respectively. Both helices are positioned
on one side of the  sheet. The hydrophobic residuesstabilizes binding of eIF2 to Met-tRNAiMet (Yatime et al.,
2004), which is consistent with the previously proposed located between the  sheet and the  helices in the
CTD are relatively well conserved among all speciesmodels that eIF2 plays a role in binding to Met-tRNAiMet
and the 40S ribosomal subunit. Two sui2 suppressor (see yellow areas in Figure 1). The C-terminal segment
following Thr280 has no fixed orientation relative to themutants, which allow more frequent recognition of UUG
as a start codon, were isolated by Cigan et al. (1989). CTD, but sequential and medium-range NOEs indicate
that it contains a single helical structure, 8. The latterOne contains the mutation P13S and the other V19F,
and their positions in the primary sequence are indicated has no apparent amphipatic character. The C-terminal
region after about Pro274 is only found in eukaryotesby red open squares in Figure 1. These residues are
conserved in most eIF2s, including the human protein. and contains many negatively charged residues (Figure
1). These residues may be relevant for an interactionThe authors reported decreased levels of eIF2 in the
mutant strains, indicating a defect in folding and/or sta- with a positively charged molecular surface, such as
formed by Arg/Lys-rich regions found in several eIFs,bility. Interestingly, the two mutation positions are close
to each other in the tertiary structure (shown in red in including eIF2. Negative charges may also be impor-
tant for directing this flexible region away from RNA andFigure 4). Pro13 and Val19 are located in the turn prior
to strand 1 and at the second residue of strand 1, making them available for protein-protein interactions.
respectively. We tried to examine whether the P13S and
V19F mutants of eIF2 still have the same tertiary struc- S51D Mutation Has Little Effect
on the eIF2 Structureture as wild-type eIF2 by NMR. The bacterially overex-
pressed mutant NTDs were found only in the insoluble Several reports have shown that the phosphomimetic
mutant, S51D, has a similar function as phosphorylatedphase, and we could not purify them (data not shown).
Since the mutation positions are close to the interface eIF2 in terms of inhibition of guanine nucleotide ex-
change activity of eIF2B (Sudhakar et al., 2000), forma-between the S1 and the -helical subdomains, it is likely
that these mutations induce exposure of residues from tion of stress granules (Kedersha et al., 2002), or induc-
tion of apoptosis (Srivastava et al., 1998). Therefore, wethe hydrophobic core between the subdomains on the
surface and destabilize the NTD structure, which could decided to analyze this mutant by NMR. In Figure 5A,
the 1H-15N HSQC spectra of se-heIF2 (black) and S51D-be responsible for the suppressor activity.
se-heIF2 (red) are overlaid. Although most of the peaks
were not affected by the S51D mutation, some peaksThe C-Terminal Domain Adopts an -Fold
The CTD contains five  strands (strands 6–10), two moved, such as His46 or Ser48. The combined chemical
shift differences of the amide groups were calculated helices (helices6 and7), and one loosely associated
C-terminal helix 8 that has no well-defined orientation (Figure 5B) and mapped onto the tertiary structure (Fig-
ure 5C). Residues that differ by more than 0.1 ppm arerelative to the CTD or the NTD (Figures 2B and 2C). The
five  strands form a single antiparallel  sheet that found only near residue 51, and the biggest difference
is only about 0.25 ppm for S48. This fact strongly sug-forms a contiguous surface area. The strands are ar-
Solution Structure of Human eIF2
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Figure 5. NMR Analysis of S51D Mutant
(A) The 1H-15N HSQC spectra of se-heIF2 and S51D-se-heIF2 are shown with black and red, respectively, overlaid in the same frame.
(B) A scatter plot of combined chemical shift differences of amide groups versus residue numbers is shown. The chemical shift differences
between se-heIF2 and S51D-se-heIF2 are combined as [(1HN)2  (15N/5)2]1/2. The residue numbers whose chemical shift difference is more
than 0.1 ppm are shown in the figure.
(C) The ribbon model of heIF2 is colored according to the combined chemical shift differences. The mutated S51 is colored in magenta. The
residues which have differences of more than 0.2 ppm, between 0.2 and 0.1 ppm, and between 0.1 and 0.05 ppm are colored in red, orange,
and green, respectively. The residues with differences less than 0.05 ppm are colored in gray, and the undetected and proline residues are
colored in white.
gests that the S51D mutation introduces only a minimal The CTDs of eIF2 and eEF1B Have Similar
Tertiary Structuresconformation change at the backbone level. Although
it is possible that phosphorylation of eIF2 has an effect Unexpectedly, the structure of the CTD in heIF2 was
found very similar to that of the CTD of eEF1B, evendifferent from the S51D mutation, it seems unlikely that
the reason for the enhanced affinity to eIF2B is found though there is no detectable sequence homology (Fig-
ures 1, 6A, and 6B). Both domains have exactly thein the conformation of free eIF2. It is more likely that
phosphorylated eIF2 and possibly the S51D mutant same topology, , 2.9 A˚ rmsd for 77 C atoms
compared, DALI Z score of 6.5 (scores 2.0 are statisti-engage in tighter binding with eIF2B due to a better
surface complementarity and/or more favorable electro- cally significant), and similar molecular shapes and sur-
faces. The CTD of eEF1B alone can function as a GEFstatic interactions.
Structure
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Figure 6. Structural Relationship between eIF2/eIF2 and eEF1B/eEF1A
(A) The ribbon presentations of the CTD in human eIF2 and P. abyssi archael eIF2 are shown. The helices and strands in eIF2 are shown
in red and orange, respectively, and those in eIF2 in light blue and green, respectively. GDP (colored in black, red, and blue), Mg2 (colored
in silver), and Zn2 (colored in orange) bound to eIF2 are shown in CPK representation. The 7/8 region is colored in magenta. The side
chains of Leu229 and Asp298 in P. abyssi archaeal eIF2 (corresponding to residues Leu256 and Asp325 in M. jannaschii archaeal eIF2) are
shown in red. The side chains of Arg243 and Lys275 in eIF2 are shown in green. The hypothetical interaction area of eIF2 with eIF2 is
circled in magenta, and that of eIF2 with Leu229/Asp298 in eIF2 in cyan.
(B) The ribbon presentation of eEF1B:eEF1A:GDP complex structure is shown in the same manner as (A); the coloring of eEF1B and eEF1A
is the same as that of eIF2 and eIF2, respectively. The side chain of Lys205 in eEF1B is shown in green. The adenine base mimic residue,
Phe163, is shown in red.
(C) Model for the complex between eIF2, Met-tRNAiMet, and the eIF2-CTD, based on the structures of archaeal eIF2 and the EF1A:GDPNP:Phe-
tRNAPhe complex (Nissen et al., 1995; Roll-Mecak et al., 2003; Yatime et al., 2004). The coloring of the surface representation of the eIF2-CTD
is based on the sequence conservation, using the same colors as in Figure 1.
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for the G protein eEF1A, which is structurally and func- between strand 6 and helix 6 in eIF2 (the region
circled with cyan in Figure 6A). According to the pro-tionally homologous to bacterial EF1A and the  subunit
of eIF2 (eIF2). The G proteins of the eEF1A and EF1A posed interaction mode between eIF2-CTD and eIF2,
the NTD of eIF2 may be located close to the G domainfamily consist of three domains: the G domain (also
called domain I), domain II, and domain III. The G domain of eIF2. This is consistent with the previously proposed
model that eIF2 works as a regulatory subunit in eIF2,can bind a GDP or a GTP molecule. GTP-loaded eEF1A
can bind aa-tRNA (ternary complex) and transfers it to where the phosphorylation state of Ser51 in the NTD
controls binding to the GEF eIF2B (Hinnebusch, 2000).the A site on the ribosome. The complex structure of
yeast eEF1B CTD:eEF1A:GDP has been solved and is In further support of the model presented here for the
interaction between eIF2 and , it was recently reportedshown in Figure 6B (Andersen et al., 2001).
The crystal structure of archaeal eIF2 from Pyrococ- that the CTD of archaeal eIF2 is necessary and sufficient
for both binding to eIF2 and for stabilization of Met-cus abyssi has been solved (shown in Figure 6A), and
it adopts a structure similar to eEF1A or EF1A, as ex- tRNAiMet binding to eIF2 (Yatime et al., 2004).
The archaeal eIF2 possesses a zinc knuckle struc-pected from their sequence homology (Schmitt et al.,
2002). eIF2, the largest subunit of eIF2, is also a G ture in the G domain (Schmitt et al., 2002), and the bound
zinc ion is shown by an orange ball in Figure 6A. Thisprotein and able to bind to Met-tRNAiMet with eIF2,
eIF2, and GTP. The tertiary structures of all three do- structure had not been identified in the other EF1A-like
proteins. Since it is located near the currently proposedmains in eIF2 and eEF1A are very similar to each other,
while the orientation between the G domain and do- eIF2 binding region, it might also interact with eIF2.
However, the primary sequences around the knucklemains II and III is slightly different (Roll-Mecak et al.,
2003; Schmitt et al., 2002). The G domain of archaeal eIF2 structure are less conserved than the other region in
eIF2. In addition, the four cysteines forming a zinc bind-is rotated toward domain II by about 30, compared to the
G domain of eEF1A in the eEF1B CTD:eEF1A structure. ing pocket in archaeal eIF2 are not conserved in the
higher eukaryotes. In the case of the human eIF2, threeAlthough it is known that eIF2 and eIF2 can form a
stable dimer (Oldfield and Proud, 1992; Schmitt et al., of the four cysteins are replaced by one leucine and
two threonines. Thus, it is unclear if the same knuckle2002), the interaction interface is not known. It is easy
to realize that if two pairs of structurally homologous part- structure as the archaeal eIF2 still exists in the higher
eukaryotic eIF2s.ners, like eEF1A:eEF1B and eIF2:eIF2, interact, they
are likely to use the same binding interface. Since the
 subunit in eIF2B has been identified as a catalytic
A Possible Mechanism for the Functionsubunit of GEF for eIF2 (Gomez et al., 2002; Gomez and
of the eIF2 CTD in eIF2Pavitt, 2000), the functional relationship between eIF2
A key residue for the guanine-nucleotide exchange ac-and eIF2 appears to be different from that between
tivity of eEF1B is Lys205 (indicated by a green filledeEF1B and eEF1A. However, the structural homology
circle in Figure 1), which inserts into the Mg2 and GDP/revealed here strongly suggests that the binding mode
GTP binding pocket of eEF1A (Figure 6B) (Andersen etbetween eEF1B and eEF1A could be similar to that
al., 2001). In yeast, the K205A mutation in eEF1B isbetween eIF2 and eIF2, using a homologous interface
lethal, very likely because of the defect of GTP/GDPon domain II and possibly the G domain (marked with
exchange on eEF1A. In the proposed model for thea dashed ellipse in Figure 6A). This model is also sup-
eIF2/eIF2 interaction, the CTD of eIF2 might comeported by the fact that the hypothetical eIF2 binding
close to the Mg2 and GDP/GTP binding pocket of eIF2.surface of the eIF2-CTD shows much higher sequence
Interestingly, Arg243 and/or Lys275 in the CTD of heIF2conservation than the rest of the CTD, as shown in yellow
are located at a similar site as Lys205 in eEF1B (Figurein Figure 6C.
6A). These positions are occupied by basic residues inIn order to examine the interaction between heIF2
other eukaryotic eIF2s (indicated by green open circlesand heIF2 in vitro, we prepared recombinant heIF2
in Figure 1). In eukaryotes, eIF2B is known to act as aeither as a glutathione S-transferase-fusion protein (Amer-
guanine-nucleotide exchange factor for eIF2, but thesham) or a streptococcal protein G B1 domain-fusion
precise molecular mechanism of its function has notprotein (Zhou et al., 2001) in an Escherichia coli expres-
been elucidated. Thus, it is interesting to examine whethersion system. Some of the protein was expressed in the
Arg243 or Lys275 in eIF2 plays any role in the guanine-soluble phase. However, we could not detect binding
nucleotide exchange reaction for eIF2. In archaeal eI-between heIF2 and heIF2 by pull-down assays (data
F2s, there is a conserved lysine at the human positionnot shown), either because the recombinant heIF2 pro-
244, and a conserved basic residue is found at the hu-tein is not functional or other components are needed
man position 272. These positions are labeled with greenfor binding, such as Met-tRNAi or eIF2. Recently, Roll-
open stars in Figure 1. According to the proposed modelMecak and colleagues showed that residues around
for the eIF2/eIF2 interaction, the side chains of theseLeu256 and Asp325 in domain II of M. jannaschii arch-
residues in archaeal eIF2 may come close to the Mg2aeal eIF2 are responsible for binding to archaeal eIF2
and GDP/GTP binding pocket of archaeal eIF2. Since(the corresponding residues, Leu229 and Asp298, in
archaea do not have an eIF2B homolog, one of thesePyrococcus abyssi archaeal eIF2 are shown in red in
residues may function in stimulating guanine-nucleotideFigure 6A) (Roll-Mecak et al., 2003). These residues
exchange of archaeal eIF2.in eIF2 are located in the hypothetical interaction sur-
An interesting structural difference between eIF2face with eIF2-CTD and could be interacting with resi-
dues around the N terminus of strand 9 and the loop and eEF1B was found for the length of strands 7 and
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8, which in eIF2 are shorter than the corresponding factor eEF1B-CTD suggests a model for the topology
of association of eIF2, eIF2, and Met-tRNAiMet in thestrands in eEF1B (shown with magenta in Figures 6A
and 6B). It is known that eEF1A is not able to bind both ternary complex. The geometry of the putative eIF2/
eIF2 interface suggests a possible role of eIF2 for theeEF1B and aa-tRNA simultaneously. The eEF1A:eEF1B
complex structure and the mutant analysis suggested GDP/GTP exchange in eIF2. This will stimulate fur-
ther mechanistic studies, once difficulties of preparingthat Phe163 in eEF1B mimics the adenine base of the
CCA end in the aa-tRNA and occupies the adenine bind- folded and functional human eIF2 are overcome.
ing pocket in eEF1A (shown with red in Figure 6B) (Ande-
Experimental Proceduresrsen et al., 2000). If the eEF1B  strands corresponding
to strands 7 and 8 in eIF2 were as short as those in
Sample Preparation
eIF2, a space could be created for eEF1A to interact Plasmid construction, protein expression, and purification for se-
with aa-tRNA in the presence of eEF1B. This logic heIF2 were performed as described (Ito and Wagner, 2004). For
might explain why the GTP-bound eIF2 is able to bind 2H, 13C, or 15N-isotope labeling, 2H2O, [13C6]-D-glucose, or 15NH4Cl
was used generally as an isotope source in M9 minimal medium. ToeIF2 and Met-tRNAiMet simultaneously. This hypothesis
obtain a FY-aromatic 1H-labeled sample (FY-sample), phenylalanineis supported by the genetic and biochemical assays
and tyrosine were added to M9 medium containing 2H2O, [2H7]-by Roll-Mecak and colleagues showing that the eIF2
D-glucose 30 min before the induction. To obtain an ILV-methyl
mutation around the putative adenine binding pocket specific 1H/13C-labeled sample (ILV-sample) for the chemical shift
(Gly319 and Arg242 in M. jann. eIF2) affected binding assignments, [U-13C4/3,3-2H2]--ketobutyrate and [U-13C5/3-2H1]--keto-
to Met-tRNAiMet, but not binding to eIF2 (Roll-Mecak et isovalerate (Cambridge Isotope Laboratories, Andover, MA) were
added to M9 medium containing 2H2O, [U-13C6/U-2H7]-D-glucose andal., 2003). Consistently with this, a previous study had
15NH4Cl 30 min before the induction (Goto et al., 1999). To obtain ashown that eIF2 plays a role in binding to Met-tRNAiMet
U-2H-/U-15N-/ILV-methyl-1H,13C-/FY-1H-labeled sample (ILVFY-sam-(Nika et al., 2001). Our current results suggest that the
ple) for the various NOESY measurements, [-13C1]--ketobutyrate,CTD of eIF2may be responsible for this function, stabi- [,-13C2]--ketoisovalerate, [15N]-phenylalanine, and [15N]-tyrosine
lizing the interaction between eIF2 and Met-tRNAiMet. were added 30 min before the induction to M9 medium containing
This is supported by the very recent study showing that 2H2O, [2H7]-D-glucose, and 15NH4Cl (Gross et al., 2003; Hajduk et al.,
2000).the eIF2-CTD is responsible for binding eIF2, and
DNA fragments encoding N-terminal (4–185) and C-terminal (185–these two components are sufficient for binding Met-
302) domains of se-heIF2 were inserted into pET-30a() plasmids,tRNAiMet in the archaeal system (Yatime et al., 2004). and the expressed proteins had a C-terminal His6-tag. The sameThe high degree of structural similarity between arch- protocol as for full-length se-heIF2was used to purify overexpressed
aeal eIF2 and EF1A allowed modeling of the interaction N-terminal and C-terminal domains of se-heIF2 (N-se-heIF2 and
of eIF2 with Met-tRNAiMet, based on the structure of C-heIF2). The expression plasmids for S51D-se-heIF2 were pre-
pared with the Quick-Change Mutagenesis Kit (Stratagene), and anthe ternary complex EF1A:GDPNP:Phe-tRNAPhe (Nissen
NMR sample was prepared as for se-heIF2.et al., 1995; Roll-Mecak et al., 2003; Schmitt et al., 2002).
This model of the complex is further supported by site-
NMR Spectroscopydirected mutagenesis studies of eIF2 (Roll-Mecak et
NMR spectra were recorded at 298 K on a CMR G 750 MHz, a Varian
al., 2003; Yatime et al., 2004). According to our model Inova 750 MHz, a Bruker Avance 600 MHz, a Bruker Avance 500
for the eIF2-eIF2 interaction, eIF2 would “line” the MHz, or a Varian Inova 500 MHz spectrometer. Some of the spectra
were measured using a Bruker Cryoprobe or a Varian Coldprobe.Met-tRNAiMet binding pocket on domain II of eIF2 and
NMR buffer conditions and the strategy for the backbone assign-come in close proximity to the tip of Met-tRNAiMet. To
ments of se-heIF2 were described elsewhere (Ito and Wagner,test this model, we performed direct NMR titration ex-
2004), and all NMR measurements were performed under the sameperiments of 15N-labeled eIF2-CTD with unmodified
conditions. 3D TROSY-H(CCO)NH, 3D TROSY-C(CO)NH, and 3D
and uncharged initiator tRNAiMet. No spectral changes HCCH-TOCSY spectra were measured to assign chemical shifts of
were detected in the 1H-15N HSQC spectra of eIF2-CTD ILV-methyl group with an ILV-sample (Hilty et al., 2002). In order to
assign chemical shifts of aromatic protons in phenylalanine andupon addition of tRNAiMet (data not shown). This is in con-
tyrosine, 2D NOESY (75 ms mixing time) and 2D TOCSY (50 mstrast to biochemical data in archaea, where eIF2-CTD
mixing time) were measured with a FY-sample in 2H2O (99.9%)was reported to bind RNA nonspecifically (Yatime et al.,
NMR buffer. Chemical shifts of 15 valine and 19 leucine methyl2004). This suggests that in eukaryotes both eIF2 and
groups were stereospecifically assigned by using a 15% 13C-labeled
eIF2 are needed for tight binding Met-tRNAiMet. A model sample (Neri et al., 1989).
of the complex between the CTD of eIF2, eIF2, and To obtain distance restraints with se-heIF2, 4D 13C/13C-edited
Met-tRNAiMet that is consistent with the data discussed HMQC-NOESY-HMQC, 3D 15N-edited NOESY-HSQC, 3D 13C-edited
HMQC-NOESY, 3D 13C/15N-edited HMQC-NOESY-HSQC, and 2Dabove is shown in Figure 6C. This could provide an
NOESY were measured with 200 ms mixing time using an ILVFY-explanation for the observed stabilization by eIF2 of
sample. The 13C dimension in all NOESY measurements was focusedMet-tRNAiMet binding to eIF2 (Yatime et al., 2004). By on the ILV-methyl region. 3D 13C-edited HMQC-NOESY and 2D
promoting tight binding of Met-tRNAiMet to eIF2, eIF2 NOESY were measured in 2H2O (99.9%) NMR buffer.
indirectly provides extra protection of Met-tRNAiMet from 1HN, 15N, and 1H chemical shifts of N-se-heIF2 and C-heIF2
deacylation (Yatime et al., 2004). It is also possible that were assigned using 3D 15N-edited NOESY-HSQC (120 ms mixing
time) and 3D 15N-edited TOCSY-HSQC (38 ms mixing time) measuredeIF2 directly contributes to protection of Met-tRNAiMet
with 15N-labeled samples, and using 2D NOESY (100 ms mixingin the bound state.
time) and 2D TOCSY (43 ms mixing time) measured with nonlabeledThe work presented here showed that heIF2 consists
samples in 2H2O (99.9%) NMR buffer. In order to assign otherof two domains that are mobile relative to each other.
chemical shifts of side chains in C-heIF2, 3D HNCA, 3D H(CCO)NH,
The loop around Ser51, which is the target of regulatory 3D C(CO)NH, 3D HCCH-TOCSY, 3D 13C-edited NOESY-HSQC were
kinases, is relatively mobile in solution. The unexpected measured using a 13C/15N-labeled sample.
To assign backbone chemical shifts of S51D-se-heIF2, 3Dstructural similarity of the eIF2-CTD with the elongation
Solution Structure of Human eIF2
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TROSY-HNCA, 3D TROSY-HN(CO)CA, 3D TROSY-HNCO, and 3D Received: June 7, 2004
Revised: July 12, 2004TROSY-HN(CA)CO were measured with a 2H/13C/15N-labeled sample.
All spectra were processed with NMRPipe (Delaglio et al., 1995) and Accepted: July 13, 2004
Published: September 7, 2004analyzed with NMRView (Johnson and Blevins, 1994).
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